v3.22.2.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flow from Operating Activities:    
Net (loss) income available to common stockholders $ (14,954) $ 8,470
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Shares and warrants issued to third parties for services 0 46
Depreciation and amortization 1,265 1,255
Amortization of debt issuance costs and discounts 39 1,785
Share-based compensation 2,454 3,517
Change in fair value of warrant liabilities 0 (23,463)
Payable-in-kind interest expense on notes payable 0 1,110
Amortization of prepaid assets 2,095 891
Other 638 (981)
Changes in operating assets and liabilities:    
Accounts receivable, net (2,901) (2,893)
Inventories, net (6,877) 1,445
Prepaid expenses and other assets (257) 680
Accounts payable and accrued liabilities 466 (8)
Other 60 (174)
Cash Used in Operating Activities (17,972) (8,320)
Cash Flow from Investing Activities:    
Capital expenditures (198) (124)
Cash Used in Investing Activities (198) (124)
Cash Flow from Financing Activities:    
Proceeds from shares and warrants issued pursuant to private placement, net 0 4,012
Share repurchases 0 (1,274)
Proceeds from revolving lines of credit 7,500 5,535
Payments on revolving lines of credit (5,000) (5,883)
Proceeds from term loan 0 6,000
Payments on term loans (650) (8,379)
Cash received for warrant exercises 0 1,685
IPO proceeds, net 0 36,160
Debt issuance costs (7) (140)
Cash Provided by Financing Activities 1,843 37,716
Net (decrease) increase in cash and cash equivalents and restricted cash (16,327) 29,272
Total cash and cash equivalents and restricted cash, beginning of period 28,942 3,989
Total cash and cash equivalents and restricted cash, end of period 12,615 33,261
Cash paid during the period for:    
Interest $ 279 $ 292

Source